Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Diabetologist
MBBS, M.Phil, Diploma in Diabetes
Endocrinologist
MBBS, MSc (Diabetes & Endocrinology)
Gastroenterologist
M.B.B.S., M.C.P.S, F.C.P.S., M.R.C.P
Hepatologist
M.B.B.S, F.C.P.S (Gastroenterology)
Family Physician
M.B.B.S, D.D.M
Diabetologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
MCPS-HPE Scholar, CHPE (Pakistan), OJT Infectious Diseases (UK), Diploma in Diabetes (UK), MBBS, FCPS (Medicine), HIV management in Resource poor settings
Internal Medicine Specialist
MCPS-HPE Scholar, CHPE (Pakistan), OJT Infectious Diseases (UK), Diploma in Diabetes (UK), MBBS, FCPS (Medicine), HIV management in Resource poor settings
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures